Similarly, Yang et al. have identified GSN as a key prognostic hub in bladder cancer, where its expression correlates with disease progression and serves as a central mediator in gene co-expression networks that govern tumor aggressiveness [33]. This evidence concerns the gene GSN and neoplasm.